CKD Bio Corp
KRX:063160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yellow Pages Ltd
TSX:Y
|
CA |
CKD Bio Corp
Long-Term Debt
CKD Bio Corp
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CKD Bio Corp
KRX:063160
|
Long-Term Debt
₩18.3B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
55%
|
|
|
Yuhan Corp
KRX:000100
|
Long-Term Debt
₩72.4B
|
CAGR 3-Years
177%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Long-Term Debt
₩40.5B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Long-Term Debt
₩96.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-10%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Long-Term Debt
₩23.4B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Long-Term Debt
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CKD Bio Corp
Glance View
CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-12-11. The firm mainly provides antibiotic ingredients, consisting of demethylchlortetracyclines (DMCTs) and rifampicins. The company also provides immunosuppressive agents, including cyclosporin and tacrolimus; remedies for diabetes, such as acarbose, and potassium clavulanate used for beta-lactam inhibitors. The firm distributes its products within domestic market and to overseas markets, such as America, China, Europe, Africa, Southeast Asia, Latin America and the Middle East.
See Also
What is CKD Bio Corp's Long-Term Debt?
Long-Term Debt
18.3B
KRW
Based on the financial report for Dec 31, 2025, CKD Bio Corp's Long-Term Debt amounts to 18.3B KRW.
What is CKD Bio Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
55%
Over the last year, the Long-Term Debt growth was -70%. The average annual Long-Term Debt growth rates for CKD Bio Corp have been -39% over the past three years , -21% over the past five years , and 55% over the past ten years .
